INT92493
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
While FPs expressed a need for guidelines on cancer follow-up, several guidelines have been published. | |||||||||||||||
| |||||||||||||||
|
Clinical practice guidelines (CPGs) can provide FPs with information and guidance on evidence-based best practices. | |||||||||||||||
| |||||||||||||||
|
OBJECTIVES: Effects of acute morphine and buprenorphine on the expression of acoustic fear-potentiated startle (FPS) and naloxone pretreatment were assessed. | |||||||||||||||
| |||||||||||||||
|
If FPs rely on the initiative of the DNs, unaware of the unsatisfactory grounds for relying on the DN, the home care patients will be left without proper support for their medical treatment.
| |||||||||||||||
| |||||||||||||||
|
One reason FPs did not know which of their patients had home care was that FPs and DNs worked in different organisations. | |||||||||||||||
| |||||||||||||||
|
Factors that influence FPs' experiences of satisfactory grounds for relying on the DNs | |||||||||||||||
| |||||||||||||||
|
Factors that influence how much of the initiative the FPs retain | |||||||||||||||
| |||||||||||||||
|
All but three FPs worked in the same organisation as the DNs. | |||||||||||||||
| |||||||||||||||
|
The FPs' working conditions | |||||||||||||||
| |||||||||||||||
|
As the FPs were usually fully booked, it was difficult to manage emergency home visits.
| |||||||||||||||
| |||||||||||||||
|
The FPs expected the DNs to assess the need for and provide necessary home care, manage contacts and meet with family and neighbours, home help staff and hospitals to coordinate care and treatment. | |||||||||||||||
| |||||||||||||||
|
It may be possible to use the presence of these slow FPs and the effect of trial PVG DBS on both the clinical status and the FPs to predict the probable success of future pain control in individual patients. | |||||||||||||||
| |||||||||||||||
|
Interestingly, we detected low frequency thalamic FPs at 0.2-0.4 Hz closely associated with the pain. | |||||||||||||||
| |||||||||||||||
|
Interestingly, we detected low frequency FPs at 0.2-0.4 Hz closely associated with the pain. | |||||||||||||||
| |||||||||||||||
|
However, the antinociceptive effect of Statins also appears to be tightly related to reducing the production of FPP in that exogenous malvonate, the precursor of FPP, reversed the antinociception by Statins in the same study. | |||||||||||||||
| |||||||||||||||
|
For FPP extractions, tissue was homogenized on ice in an ethanol/butanol/70 mM (1:1.25:1.25. v/v/v) ammonium hydroxide solution using a polytron homogenizer. | |||||||||||||||
| |||||||||||||||
|
FPP is synthesized from farnesol via two successive phosphorylation reactions mediated by farnesol kinase and farnesyl phosphate kinase, transitioning first through farnesyl monophosphate (FMP) then to FPP [20]. | |||||||||||||||
| |||||||||||||||
|
In striatal slices, acute QA application dramatically inhibited corticostriatal field potentials (FPs), whose recovery was significantly higher in CNTF rats compared to controls (? | |||||||||||||||
| |||||||||||||||
|
The highest production of FPP was measured in the brainstem (89.55E-12 ± 17.10E-12 moles/gram tissue), followed by the midbrain (56.95E-12 ± 19.89E-12) and thalamus (64.95E-12 ± 15.20E-12), moderate levels were measured in the hypothalamus (39.91E-12 ± 6.8E-12), cerebellum (33.62E-12 ± 8.94E-12), hippocampus (37.31E-12 ± 4.98E-12) and striatum (45.19E-12 ± 12.51E-12), and the lowest levels were measured in the pituitary (11.81E-12 ± 4.81E-12) and cortex (23.09E-12 ± 6.78E-12).
2.2. | |||||||||||||||
| |||||||||||||||
|
Here, we show that levels of FPP in rat cortex are ~7 ng/mg, so these levels are in an equivalent range. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.